- Home
- TELA
TELA
TELA Bio Inc.
as 04-16-2025 4:00pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | MALVERN |
| Market Cap: | N/A | IPO Year: | 2019 |
| Target Price: | $6.00 | AVG Volume (30 days): | 519.2K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.33 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.86 - $6.50 | Next Earning Date: | 05-08-2025 |
| Revenue: | $69,300,000 | Revenue Growth: | 18.56% |
| Revenue Growth (this year): | 25.99% | Revenue Growth (next year): | 25.20% |
Latest TELA Bio Inc. News
TELA Breaking Stock News: Dive into TELA Ticker-Specific Updates for Smart Investing
GlobeNewswire
17 days ago
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
Simply Wall St.
a month ago
TELA Bio Full Year 2024 Earnings: Revenues Disappoint
MT Newswires
a month ago
Sector Update: Health Care
GuruFocus.com
a month ago
TELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales Turnover
GuruFocus.com
a month ago
Earnings To Watch: TELA Bio Inc (TELA) Reports Q4 2024 Result
MT Newswires
a month ago
Top Premarket Decliners
MT Newswires
a month ago
Piper Sandler Downgrades TELA Bio to Neutral From Overweight, Adjusts Price Target to $2 From $5
Zacks
a month ago
TELA Bio, Inc. (TELA) Reports Q4 Loss, Misses Revenue Estimates
Compare TELA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TELA TELA Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.